176 related articles for article (PubMed ID: 21933426)
1. Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer.
Zhou WH; Tang F; Xu J; Wu X; Feng ZY; Li HG; Lin DJ; Shao CK; Liu Q
BMC Cancer; 2011 Sep; 11():397. PubMed ID: 21933426
[TBL] [Abstract][Full Text] [Related]
2. Low expression of Beclin 1, associated with high Bcl-xL, predicts a malignant phenotype and poor prognosis of gastric cancer.
Zhou WH; Tang F; Xu J; Wu X; Yang SB; Feng ZY; Ding YG; Wan XB; Guan Z; Li HG; Lin DJ; Shao CK; Liu Q
Autophagy; 2012 Mar; 8(3):389-400. PubMed ID: 22240664
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation that up-expression of HOXA13 is a novel independent prognostic marker of a worse outcome in gastric cancer based on immunohistochemistry.
Han Y; Tu WW; Wen YG; Li DP; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Med Oncol; 2013; 30(2):564. PubMed ID: 23592225
[TBL] [Abstract][Full Text] [Related]
4. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
5. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
6. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
[TBL] [Abstract][Full Text] [Related]
7. High RNA-Binding Motif Protein 3 (RBM3) Expression is Independently Associated with Prolonged Overall Survival in Intestinal-Type Gastric Cancer.
Ye F; Jin P; Cai X; Cai P; Cai H
Med Sci Monit; 2017 Dec; 23():6033-6041. PubMed ID: 29263314
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
9. 14-3-3sigma expression as a prognostic marker in undifferentiated nasopharyngeal carcinoma.
Chan SY; To KF; Leung SF; Yip WW; Mak MK; Chung GT; Lo KW
Oncol Rep; 2010 Oct; 24(4):949-55. PubMed ID: 20811675
[TBL] [Abstract][Full Text] [Related]
10. TPM1 is a Novel Predictive Biomarker for Gastric Cancer Diagnosis and Prognosis.
Hu L; Fang L; Zhang ZP; Yan ZL
Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255282
[TBL] [Abstract][Full Text] [Related]
11. Autophagic protein Beclin 1 serves as an independent positive prognostic biomarker for non-small cell lung cancer.
Zhou W; Yue C; Deng J; Hu R; Xu J; Feng L; Lan Q; Zhang W; Ji D; Wu J; Liu Q; Liu A
PLoS One; 2013; 8(11):e80338. PubMed ID: 24260370
[TBL] [Abstract][Full Text] [Related]
12. HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric cancer patients.
Zhao XF; Yang YS; Park YK
Int J Clin Oncol; 2020 Dec; 25(12):2044-2054. PubMed ID: 32816159
[TBL] [Abstract][Full Text] [Related]
13. Upregulated expression of long non-coding RNA LINC00982 regulates cell proliferation and its clinical relevance in patients with gastric cancer.
Fei ZH; Yu XJ; Zhou M; Su HF; Zheng Z; Xie CY
Tumour Biol; 2016 Feb; 37(2):1983-93. PubMed ID: 26334618
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of serum response factor is correlated with poor prognosis in patients with gastric cancer.
Yin J; Lv X; Hu S; Zhao X; Liu Q; Xie H
Hum Pathol; 2019 Mar; 85():10-17. PubMed ID: 30500416
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of SLP-2 correlate with poor prognosis in gastric cancer.
Liu D; Zhang L; Shen Z; Tan F; Hu Y; Yu J; Li G
Gastric Cancer; 2013 Oct; 16(4):498-504. PubMed ID: 23371255
[TBL] [Abstract][Full Text] [Related]
16. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z
World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of Rap1GAP as a prognostic biomarker for primary gastric cancer patients.
Zhao J; Mai C; Weng D; Chen C; Zhou Z; Liu Y; Zhou Z; Wang P
Cancer Biomark; 2018; 22(3):375-384. PubMed ID: 29758923
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.
Liu D; Sun L; Tong J; Chen X; Li H; Zhang Q
Tumour Biol; 2017 Jun; 39(6):1010428317701443. PubMed ID: 28631563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
